FDA approves Glaxosmithkline Plc's Flonase Allergy Relief for sale over-the-counter in The United States


Thursday, 24 Jul 2014 01:32pm EDT 

Glaxosmithkline plc:Announces that the U.S. Food and Drug Administration (FDA) has approved Flonase Allergy Relief.Flonase Allergy Relief containing the No. 1 prescribed allergy treatment ingredient1, as an over-the-counter (OTC) treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies.2.Flonase Allergy Relief is the first and only over-the-counter nasal spray indicated for relief of all nasal and eye-related allergy symptoms3,4including runny nose, sneezing, itchy nose5-7, nasal congestion8-11and itchy and watery eyes. 

Company Quote

47.02
0.36 +0.77%
27 Mar 2015